Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Actuant Corporation on the acquisition of CrossControl AB
Mandate

Vinge advises Actuant Corporation on the acquisition of CrossControl AB

August 22, 2012

Vinge is advising Actuant Corporation in connection with the acquisition of CrossControl AB. CrossControl is a leading provider of advanced electronic solutions for user-machine interaction, vehicle control, and mobile connectivity in critical environements and has annual revenues of approximately $40 million. Actuant Corporation is a diversified industrial company with operations in more than 30 countries.

The Vinge team advising Actuant Corporation includes partner Johan Göthberg, associates Karl Svantemark, Rime Dreber and Karl Hahtovirta. Counsel Maria Schultzberg provides tax law advice and Åsa Gotthardsson is providing employment law advice.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026